Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
124 employees · est. 2019 · United States
Imcyse SA
Pioneering the development of Imotopes™ to prevent, stop and potentially cure autoimmune diseases
17 employees · est. 2011 · Liege, Belgium
Imcyse SA is the older company (2019 vs 2011); Dianthus Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Dianthus Therapeutics, Inc. | Imcyse SA |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2011 older |
| Headquarters | ||
| Headquarters | United States | Liege, Belgium |
| Employees | ||
| Employees | 124 larger | 17 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health and Wellness, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Series B |
| Total Funding | ||
| Total Funding | $351.50M | $55.90M |
| Funding Rounds | ||
| Funding Rounds | 4 | 4 |
| Services | ||
| Services | Development of Therapies for Severe Autoimmune Diseases, Engineering of Antibodies for Disease Pathology | Development of immunotherapies, Clinical trials for autoimmune diseases, Partnership-driven commercialization |
| Target Customers | ||
| Target Customers | Patients with Severe Autoimmune Diseases, Healthcare Providers, Pharmaceutical Researchers | Patients with autoimmune diseases, Healthcare institutions, Pharmaceutical partners, Academic researchers |
| Taxonomy | ||
| Taxonomy | Monoclonal Antibodies, Selectivity, Potency, Clinical-stage, Autoimmune Diseases, Inflammatory Diseases, Complement Therapeutics, New York City, Waltham, Massachusetts, Stealth Mode, Pharmaceuticals, Drug Development, Precision Medicine | Autoimmune Diseases, Active Specific Immunotherapy, Imotopes™, Type 1 Diabetes, Immunotherapies, Cytolytic CD4 T-cells, Antigen-Presenting Cells, Synthetic Peptides, Biopharmaceuticals, Clinical Trials, Multiple Sclerosis, Intellectual Property, Imcyse Technology Platform, Chronic Autoimmune Diseases |
| Website | ||
| Website | dianthustx.com | imcyse.com |
About Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2019 and strategically headquartered in the United States, located in New York City and Waltham, Massachusetts. Their slogan, "Unlocking the full potential of complement therapeutics through the power of selectivity," h...
About Imcyse SA
Imcyse SA, headquartered in Belgium, is a pioneering player in the biopharmaceutical sector, advancing a novel class of immunotherapies to combat severe autoimmune diseases. Founded in 2011 as a spin-off from the Catholic University of Leuven (KULeuven), the company has carved a niche with its cutti...
We will tell you when either one moves
BounceWatch watches Dianthus Therapeutics, Inc. and Imcyse SA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Dianthus Therapeutics,... and Imcyse SA — by email.
Frequently Asked Questions
Compare Dianthus Therapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Dianthus Therapeutics, Inc. on 9 Jun 2026, and Imcyse SA on 23 Feb 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
